Alan was founded in 2016 by Jean-Charles Samuelian-Werve and Charles Gorintin . The company operates a digital health insurance and AI-powered preventive healthcare platform, serving over 1.1 million members and 37,000 businesses across France, Spain, Belgium, and Canada . As of Q1 2026, Alan reported approximately €800 million in annual recurring revenue (ARR), representing 53% year-over-year growth, and the company is profitable in France . The company employs approximately 850 people .
In March 2026, Kylian Mbappé became a minority shareholder and brand ambassador for Alan through his investment fund Coalition Capital . Alan described the arrangement not as a sponsorship deal but as Mbappé joining the company as an "investor and teammate" who will be integrated into the product via Alan Play, where users can access health content linked to Mbappé's routines around sleep, nutrition, and mental health .
Alan stated the funds will be deployed toward:
With a credible path toward €1 billion ARR by year-end 2026 , Alan's Series G signals continued investor appetite for AI-driven health insurance platforms that prioritize prevention over traditional sick-care models.
Alan was founded in 2016 by Jean-Charles Samuelian-Werve and Charles Gorintin . The company operates a digital health insurance and AI-powered preventive healthcare platform, serving over 1.1 million members and 37,000 businesses across France, Spain, Belgium, and Canada . As of Q1 2026, Alan reported approximately €800 million in annual recurring revenue (ARR), representing 53% year-over-year growth, and the company is profitable in France . The company employs approximately 850 people .
In March 2026, Kylian Mbappé became a minority shareholder and brand ambassador for Alan through his investment fund Coalition Capital . Alan described the arrangement not as a sponsorship deal but as Mbappé joining the company as an "investor and teammate" who will be integrated into the product via Alan Play, where users can access health content linked to Mbappé's routines around sleep, nutrition, and mental health .
Alan stated the funds will be deployed toward:
With a credible path toward €1 billion ARR by year-end 2026 , Alan's Series G signals continued investor appetite for AI-driven health insurance platforms that prioritize prevention over traditional sick-care models.